一种治疗冠心病的中药组合物及其制备方法与应用
By combining traditional Chinese medicines such as Panax notoginseng, Spatholobus suberectus, Salvia miltiorrhiza, Gynostemma pentaphyllum, Pueraria lobata, and Ficus hirta with traditional Chinese medicine theory, and preparing them into granules or decoctions, the problem of insufficient efficacy of existing traditional Chinese medicines in treating coronary heart disease has been solved, and safe and effective symptom improvement has been achieved.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- GUANGXI INT ZHUANG MEDICINE HOSPITAL
- Filing Date
- 2024-08-21
- Publication Date
- 2026-07-17
AI Technical Summary
Existing traditional Chinese medicines are not effective enough in treating coronary heart disease with complex syndromes and have adverse reactions, making it difficult to meet clinical needs.
Based on Zhuang medicine theory, this formula combines Chinese herbs such as Panax notoginseng, Spatholobus suberectus, Salvia miltiorrhiza, Gynostemma pentaphyllum, Pueraria lobata, and Ficus hirta to prepare granules or decoctions. Through decoction and concentration methods, steviosides and dextrin are added to granulate the formula, which is used to treat symptoms such as chest tightness, chest pain, palpitations, and shortness of breath caused by qi deficiency and blood stasis.
It significantly improves cardiovascular microcirculation, relieves symptoms of coronary heart disease, has high safety with no obvious adverse reactions, and has the effects of invigorating qi and blood circulation, clearing the meridians and relieving pain.
Smart Images
Figure BDA0005004027090000131 
Figure BDA0005004027090000141 
Figure BDA0005004027090000142